Related Experiment Videos

Transluminal balloon coarctation angioplasty: experience with 27 patients

Insights

Transluminal balloon angioplasty (BA) safely treats coarctation of the aorta (COA). This effective procedure significantly reduces pressure gradients and increases aortic diameter in patients of all ages.

Area of Science:

  • Cardiology
  • Pediatric Cardiology
  • Interventional Cardiology

Background:

  • Coarctation of the aorta (COA) is a congenital heart defect requiring intervention.
  • Surgical repair may lead to restenosis, necessitating alternative treatments.
  • Infants with preductal COA often present with critical illness.

Purpose of the Study:

  • To evaluate the safety and efficacy of transluminal balloon angioplasty (BA) for coarctation of the aorta (COA).
  • To assess the impact of BA on pressure gradients and aortic diameter in diverse patient groups.

Main Methods:

  • Transluminal balloon angioplasty (BA) was performed in 27 patients with COA (infants, post-surgical restenosis, unoperated).
  • Sequential balloon inflations to 100-120 psi were used across the coarctation site.
  • Pressure gradients and aortic dimensions were measured before, immediately after, and during follow-up (3-24 months).

Main Results:

  • BA was performed without complications in all patients.
  • Immediately post-BA, mean systolic pressure gradient decreased significantly (49 to 10 mm Hg, p<0.01).
  • Mean COA diameter increased significantly (3.9 to 9.6 mm, p<0.01), with sustained results at follow-up.

Conclusions:

  • Transluminal balloon angioplasty is a safe and effective treatment for coarctation of the aorta.
  • BA provides significant hemodynamic and anatomic improvement in COA patients.
  • It serves as a valuable palliative option for critically ill infants with COA.

Related Concept Videos